Get started
Author

Claude A. Ribot

Observed names: C Ribot, C. Dr. Ribot, C. RIBOT, C. Ribot, CLAUDE RIBOT, Claude A Ribot, Claude Dr. Ribot, Claude Pr. Ribot, Claude Ribot, Ribot, Claude
Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), The University of Sydney, Guy's Hospital, Université Toulouse III - Paul Sabatier, Inserm, University of Liège, Concord Repatriation General Hospital, Centre Hospitalier Universitaire de Toulouse, Heritage Medical Research Clinic, Procter & Gamble (United Kingdom), Hôpital Rangueil, Hospital Universitario Central de Asturias, Hôpital Purpan, Hôpital Saint Eloi, Institut des Maladies Métaboliques et Cardiovasculaires, Hôpital Paule de Viguier, Université de Toulouse, University of Florence, Procter & Gamble (United States), University of Sheffield
OpenAlex ID: A5111595287
Risk factors for hip fracture in european women: The MEDOS study
1995 · Olof Johnell, Bo Gullberg, et al. · Journal of Bone and Mineral Research · 565
How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study
1998 · A. M. Schott, C. Cormier, et al. · Osteoporosis International · 361
Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study
1999 · J. Kanis, O. Johnell, et al. · Osteoporosis International · 355
The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling
2011 · Cyril Seillet, Sophie Laffont, et al. · Blood · 347
PDF
The variable incidence of hip fracture in Southern Europe: The MEDOS study
1994 · I. Elffors, E. Allander, et al. · Osteoporosis International · 310
Relative influence of age and menopause on total and regional body composition changes in postmenopausal women
1996 · Florence A. Trémollieres, Jean-Michel Pouilles, et al. · American Journal of Obstetrics and Gynecology · 245
Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: Sensitivity of the WHO FRAX tool
2010 · Florence A Trémollieres, Jean-Michel Pouillès, et al. · Journal of Bone and Mineral Research · 221
PDF
Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women
1993 · F A Tremollieres, J M Pouilles, et al. · The Journal of Clinical Endocrinology & Metabolism · 217
Risedronate Reverses Bone Loss in Postmenopausal Women with Low Bone Mass: Results From a Multinational, Double-Blind, Placebo-Controlled Trial
2000 · Ignac Fogelman, Claude Ribot, et al. · The Journal of Clinical Endocrinology & Metabolism · 212
Obesity and postmenopausal bone loss: The influence of obesity on vertebral density and bone turnover in postmenopausal women
1987 · C. Ribot, F. Tremollieres, et al. · Bone · 183
Coronary heart disease risk factors and menopause: a study in 1684 French women
1999 · Florence A. Trémollières, Jean-Michel Pouilles, et al. · Atherosclerosis · 150
The effects of menopause on longitudinal bone loss from the spine
1993 · J. M. Pouilles, F. Tremollieres, et al. · Calcified Tissue International · 149
Bone Mineral Density and Thyroid Hormone Therapy
1990 · C. RIBOT, F. TREMOLLIERES, et al. · Clinical Endocrinology · 138
Osteoarthritis protects against femoral neck fracture: The MEDOS study experience
1993 · J. Dequeker, O. Johnell, et al. · Bone · 136
Assessment of the risk of post‐menopausal osteoporosis using clinical factors
1992 · C. Ribot, J. M. Pouilles, et al. · Clinical Endocrinology · 134
European semi-anthropomorphic spine phantom for the calibration of bone densitometers: Assessment of precision, stability and accuracy the European quantitation of osteoporosis study group
1995 · J. Pearson, J. Dequeker, et al. · Osteoporosis International · 111
Precision and sensitivity of dual-energy X-ray absorptiometry in spinal osteoporosis
1991 · Jean-Michel Pouilles, Florence Tremollieres, et al. · Journal of Bone and Mineral Research · 111
Influence of early age at menopause on vertebral bone mass
1994 · J.M. Pouillès, F. Trémollières, et al. · Journal of Bone and Mineral Research · 103
Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX® versus EVISTA®Comparison Trial) International1
2004 · P. N. Sambrook, P. Geusens, et al. · Journal of Internal Medicine · 101
PDF
Bone Density Reduction in Various Measurement Sites in Men and Women with Osteoporotic Fractures of Spine and Hip: The European Quantitation of Osteoporosis Study
1999 · H. Kröger, M. Lunt, et al. · Calcified Tissue International · 97
Withdrawal of Hormone Replacement Therapy is Associated with Significant Vertebral Bone Loss in Postmenopausal Women
2001 · F. A. Trémollieres, J.-M. Pouilles, et al. · Osteoporosis International · 96
Effect of menopause on femoral and vertebral bone loss
1995 · J.M. Pouilles, F. Tremollieres, et al. · Journal of Bone and Mineral Research · 92
Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease
1994 · M. Laroche, J. M. Pouilles, et al. · Clinical Rheumatology · 89
Spine and femur densitometry at the menopause: Are both sites necessary in the assessment of the risk of osteoporosis?
1993 · J. M. Pouilles, F. Tremollieres, et al. · Calcified Tissue International · 84
Femoral bone density in young male adults with stress fractures
1989 · J.M. Pouilles, J. Bernard, et al. · Bone · 73
Works count: 136
Citation count: 5,764
H-index: 36
I10-index: 56
Year
Topic
Type